Caprison

Cellid, COVID-19 vaccine Korean stock

Caprison Updated   
KRX:299660   CELLID
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Trade active:
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
Trade active:
Space elevator~
Trade closed: stop reached:
Events didn't pan out as I had expected.

Too bad.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.